Pioneering the latest advances in dermatology, La Roche-Posay offers complete lines of skincare and makeup products for your face and body. All dermatologist tested and formulated for the most sensitive skin.
HOW TO APPLY:
Apply the sunscreen product just before exposure. Re-apply frequently and generously to maintain protection, especially after perspiring or towelling. External use. Over-exposure to the sun is dangerous. Even while using a sunscreen product because it does not provide 100% protection.
No white marks.
With La Roche-Posay Thermal Spring Water
For oily skin, also suitable for acne prone skin at risk of UV induced marks and post sun breakouts (rebound effect).
NIACINAMIDE, also known as Vitamin B3. Niacinamide is a multi-action active that meets the 3 major needs of patients with AK-NMSC: it stimulates the skin's natural DNA repair enzymes, improves skin barrier function through decreasing irritation, and accelerating cellular differentiation and healing.
La Roche-Posay Anthelios, recommended by 60 000 dermatologists worldwide*
*Source: Survey on the dermocosmetic market carried out by IQVIA and other partners (Ipsos, TNS) between September 2017 and August 2018 among dermatologists in 61 countries.
Lasting shine control
No white marks
Prevents UV-induced marks
LET'S TAKE A LOOK INSIDE
SALICYLIC ACID & NIACINAMIDE
A powerful blend of UV filters and anti-oxidants that goes above broad-spectrum UVA and UVB protection to shield against damage from other skin aggressors such as infrared and pollution.
WHICH ONE DO YOU NEED?
THE PERFECT MATCH
FOR YOUR SKIN
THE ANTHELIOS WINNING TRIO
GESTURE FOR A SUN EXPOSURE FOR ACNE-PRONE SKIN
DISCOVER THE OTHER
PRODUCTS OF THE RANGE
ANTHELIOS is a pioneering player in the suncare market. Its broad-spectrum, very high protection is the result of almost 30 years of advanced clinical research into Suncare and sensitive skin.
38% of people still don’t regularly protect themselves from UV*. ANTHELIOS products make everyday sun protection easy.
*Source: Skin cancer prevention global report - IPSOS LRP - February 2015